News - Neurological, Antibiotics and Infectious diseases

Filter

Popular Filters

Shire's ADHA drug Elvanse accepted for NHS use in Scotland; UK guidance on fidaxomicin

14-05-2013

Ireland-headquartered Shire plc (LSE: SHP) said yesterday (May 13) that its single-daily dose long-acting…

Antibiotics and Infectious diseasesAstellas PharmaDificlirElvanseEuropefidaxomicinNeurologicalPharmaceuticalRegulationShire

NeRRe Therapeutics created to develop NRAs from GSK; GlycoVaxyn deal with GSK

20-12-2012

NeRRe Therapeutics was launched in the UK yesterday to develop a portfolio of clinical and pre-clinical…

Antibiotics and Infectious diseasesBiotechnologyFinancialGlaxoSmithKlineGlycoVaxynLicensingNeRReTherapeuticsNeurologicalNovo NordiskPharmaceuticalResearchVaccines

Pfizer agrees $55 million settlement for off-label promotion of Protonix by Wyeth; strikes deal over Zyvox and Lyrica

13-12-2012

USA-based Pfizer (NYSE: PFE), the world's largest drugmaker by sales, has agreed to pay $55 million plus…

Antibiotics and Infectious diseasesFinancialGastro-intestinalsLegalLyricaMarkets & MarketingNeurologicalNorth AmericaPfizerPharmaceuticalProtonixWyethZyvox

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx

01-05-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said…

Antibiotics and Infectious diseasesDoryxGenericsLegalMergers & AcquisitionsMylan LaboratoriesNeurologicalNorth AmericaNuvigilPatentsPharmaceuticalTeva Pharmaceutical IndustriesWarner Chilcott

Back to top